Efficacy of SIRT radioembolisation of liver metastases of neuroendocrine tumours (NETs): A single institution experience

#4332

Introduction: Majority of NET patients develop liver metastases (NET-LM). Improved treatment of NET-LM may prolong survival. In case of liver-dominant metastatic disease, local radionuclide treatment using microspheres could be considered.

Aim(s): Evaluation of the effectiveness and safety of SIRT radioembolisation in patients with unresectable NET-LM.

Materials and methods: Retrospective analysis of radioembolisations with yttrium-90 (90Y) and holmium-166 (166Ho) microspheres in patients with unresectable NET-LM treated in 2018-2024 in MSC Oncology Institute in Gliwice, Poland. Post- treatment tumour response was assessed according to RECIST 1.1. Overall survival was analysed using Kaplan-Meier curve.

Conference:

Presenting Author: Kropinska A

Authors: Kropinska A, Gola M, Sygula A, Hamm M, Ledwon A,

Keywords: SIRT, radioembolisation, neuroendocrine tumour, liver metastasis,